Mirae Asset Global Investments’s AtriCure ATRC Stock Holding History

Mirae Asset Global Investments’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,237	Closed	-$822K	–	1605
2024 Q1	$822K	Sell	20,237 -1,000	-5%	-$33.5K	﹤0.01%	1645
2023 Q4	$758K	Buy	21,237 +484	+2%	+$18K	﹤0.01%	1759
2023 Q3	$909K	Buy	20,753 +516	+3%	+$25.2K	﹤0.01%	1564
2023 Q2	$999K	Hold	20,237	–	–	﹤0.01%	1569
2023 Q1	$839K	Hold	20,237	–	–	﹤0.01%	1632
2022 Q4	$898K	Buy	20,237 +1,155	+6%	+$48.2K	﹤0.01%	1557
2022 Q3	$746K	Buy	19,082 +5,780	+43%	+$264K	﹤0.01%	1650
2022 Q2	$544K	Buy	+13,302	New	+$630K	﹤0.01%	1705

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's ATRC Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 20,237 shares — an estimated $822K sold.

Mirae Asset Global Investments first reported a position in ATRC in Q2 2022 and held it in 8 quarters. The position peaked at $999K in Q2 2023. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

Mirae Asset Global Investments reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 20,237 AtriCure shares in Q2 2024, an estimated $822K.
Mirae Asset Global Investments first reported a position in AtriCure in Q2 2022 and held it in 8 quarters.
Mirae Asset Global Investments's AtriCure position peaked at $999K in Q2 2023.
197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.